Literature DB >> 1825853

Adenovirus E1A protein activates transcription of the E1A gene subsequent to transcription complex formation.

J Schaack1, J Logan, E Vakalopoulou, T Shenk.   

Abstract

The mechanism of transcriptional activation of the adenovirus E1A and E3 genes by E1A protein during infection was examined by using transcription-competition assays. Infection of HeLa cells with one virus led to inhibition of mRNA accumulation from a superinfecting virus. Synthesis of the E1A 289R protein by the first virus to infect reduced inhibition of transcription of the superinfecting virus, indicating that the E1A 289R protein was limiting for E1A-activated transcription. Infection with an E1A- virus, followed 6 h later by superinfection with a wild-type virus, led to preferential transcriptional activation of the E1A gene of the first virus, suggesting that a host transcription component(s) stably associated with the E1A promoter in the absence of E1A protein and that this complex was the substrate for transcriptional activation by E1A protein. The limiting host transcription component(s) bound to the E1A promoter to form a complex with a half-life greater than 24 h in the absence of E1A 289R protein, as demonstrated in a challenge assay with a large excess of superinfecting virus. In the presence of the E1A 289R protein, the E1A gene of the superinfecting virus was gradually activated with a reduction in E1A mRNA accumulation from the first virus. The kinetics of the activation suggest that this was due to an indirect effect rather than to destabilization of stable transcription complexes by the 289R protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825853      PMCID: PMC239972     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Adenovirus E1A protein paradigm viral transactivator.

Authors:  J Flint; T Shenk
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

2.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

3.  Physical analysis of transcription preinitiation complex assembly on a class II gene promoter.

Authors:  M W Van Dyke; R G Roeder; M Sawadogo
Journal:  Science       Date:  1988-09-09       Impact factor: 47.728

4.  Isolation of deletion and substitution mutants of adenovirus type 5.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1978-01       Impact factor: 41.582

5.  Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA.

Authors:  J Schaack; W Y Ho; P Freimuth; T Shenk
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

6.  Autoregulation of adenovirus E1A gene expression.

Authors:  C Tibbetts; P L Larsen; S N Jones
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

7.  The pseudorabies immediate early protein stimulates in vitro transcription by facilitating TFIID: promoter interactions.

Authors:  S M Abmayr; J L Workman; R G Roeder
Journal:  Genes Dev       Date:  1988-05       Impact factor: 11.361

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  Sequence-independent autoregulation of the adenovirus type 5 E1A transcription unit.

Authors:  P Hearing; T Shenk
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

10.  Activation of cellular promoters during herpes virus infection of biochemically transformed cells.

Authors:  R D Everett
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

View more
  1 in total

1.  E1B-55K Is a Phosphorylation-Dependent Transcriptional and Posttranscriptional Regulator of Viral Gene Expression in Human Adenovirus C5 Infection.

Authors:  Paloma Hidalgo; Yasel Garcés; Eduardo Mundo; Raúl E López; Luca D Bertzbach; Thomas Dobner; Ramón A González
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.